9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like German Biotech BioNTech Locks in $270M Series A January 3, 2018 MorphoSys AG To Present At Upcoming Investor Conferences August 9, 2017 Active Biotech's Laquinimod Fails to Meet Primary Endpoint in Phase II Trial November 30, 2017
